Benefits of near-universal vaccination and treatment access to manage COVID-19 burden in the United States

Mostrar otras versiones (1)

BACKGROUND: As we continue the fourth year of the COVID-19 epidemic, SARS-CoV-2 infections still cause high morbidity and mortality in the United States. During 2020–2022, COVID-19 was one of the leading causes of death in the United States and by far the leading cause among infectious diseases. Vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fuhan, Tran, Thu Nguyen-Anh, Howerton, Emily, Boni, Maciej F., Servadio, Joseph L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463609/
https://www.ncbi.nlm.nih.gov/pubmed/37620926
http://dx.doi.org/10.1186/s12916-023-03025-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463609/
https://www.ncbi.nlm.nih.gov/pubmed/37620926
http://dx.doi.org/10.1186/s12916-023-03025-z

Ejemplares similares